Metraipolis › archive › dc_bb1ee32be7ea

Vogt-Koyanagi-Harada Syndrome: Clinical Features, Immunogenetic Predisposition and PD-1 Inhibitor-Induced Forms-A Comprehensive Review — Europe PMC PMID:42123224

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42123224
DOI: 10.3390/jcm15093490
License (as archived): solo-consultazione
Archived: 2026-11-02T20:13:15.837Z
SHA-256 of the archived text: 4b71c1df9f3fa8d545084cd3b49e8c20d0fc030c6313f6849a7977c4d3e1eaea
Stable URL of this page: https://metraipolis.com/documento/dc_bb1ee32be7ea

How to cite

Vogt-Koyanagi-Harada Syndrome: Clinical Features, Immunogenetic Predisposition and PD-1 Inhibitor-Induced Forms-A Comprehensive Review — Europe PMC PMID:42123224 — Europe PMC (en), https://europepmc.org/article/MED/42123224 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb1ee32be7ea (Metraipolis archive dc_bb1ee32be7ea, sha256 4b71c1df9f3fa8d545084cd3b49e8c20d0fc030c6313f6849a7977c4d3e1eaea)

BibTeX

@misc{dcbb1ee32be7ea,
  title = {Vogt-Koyanagi-Harada Syndrome: Clinical Features, Immunogenetic Predisposition and PD-1 Inhibitor-Induced Forms-A Comprehensive Review — Europe PMC PMID:42123224},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123224},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb1ee32be7ea; sha256 4b71c1df9f3fa8d545084cd3b49e8c20d0fc030c6313f6849a7977c4d3e1eaea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123224. Agents can read the archived copy with the MCP tool read_document.